SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
Prosight Management, LP | 256,115 | $699,000 | 0.44% |
ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |